Edit |   |
---|---|
Antigenic Specificity | CD4, Human (Zanolimumab biosimilar) |
Clone | Zanolimumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD4 Recombinant Antibody (Zanolimumab). Zanolimumab (expected trade name HuMax-CD) is a human monoclonal antibody and an immunosuppressive drug. It was developed with the goal of treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma. Development of the drug was ultimately discontinued with termination of all trials. |
Immunogen | n/a |
Other Names | Anti-CD4 Recombinant Antibody, Research Grade Zanolimumab, Anti-Human CD4 Recombinant Antibody(Zanolimumab), HuMax-CD4, Antibody Drug Analogues, Monoclonal Antibody, YR1135, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 652153-01-0 |
Catalog # | YR1135 |
Price | please inquire |
Order / More Info | CD4, Human (Zanolimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |